What findings exist regarding ERR agonists and body fat/metabolism research?
SLU-PP-332 increases energy expenditure, fat oxidation, and improves obesity and insulin sensitivity.[1] ↗
Diet-induced obesity and ob/ob mice.
2024 issue, animal research.
View the Article Title and Full Citation+
A Synthetic ERR Agonist Alleviates Metabolic Syndrome.
The Journal of Pharmacology and Experimental Therapeutics · Volume, Issue, Year 2024
First published 2024-01-17 · PMID 37739806
DOI 10.1124/jpet.123.001733







